Allergan, is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential to see more clearly, move more freely, express themselves more fully. In 1950, pharmacist Gavin S. Herbert established Allergan Pharmaceuticals, Inc. Allergan focused on the discovery and development of novel formulations for specialty markets, as well as intimate collaboration with physicians and the scientific community. In 1953, Allergan produced eye drops and formulated new products such as the first cortisone eye drop to treat allergic inflammation and the first ophthalmic steroid decongestant. Allergan's is best known for its product, Botox. Some of the top Botox providers in the U.S. Include [Epione Beverly Hills](https://www.epionebh.com/), [EVEXIAS Medical Centers](https://evexiasmedical.com/) & [Skin Associates](https://www.skinassociatesfl.com/).

Research Grants 4 show all


$41.6M
2019

Patents 15,218show all

  • 4,682
    A61K - Preparations for medical, dental, or toilet purposes
  • 2,042
    C07D - Heterocyclic compounds
  • 1,452
    A61F - Filters implantable into blood vessels
  • 980
    C07C - Acyclic or carbocyclic compounds
  • 901
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 566
    C07K - Peptides
  • 429
    A61Q - Specific use of cosmetics or similar toilet preparations
  • 400
    A61B - Diagnosis
  • 382
    Y02A - Technologies for adaptation to climate change
  • 378
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium

Clinical Trials 1,212show all

356Phase 3260N/A190Phase 2173Phase 492Other

SEC Filings show all


167
8-K

63
10-Q

17
10-K

Contact Information

5 Giralda Farms
Madison, WI 07940
United States

Overview

Total FundingEmployeesLast Funding DateStatus
10000+Acquired